who makes ipilimumab and nivolumab?
605267
FDA approves nivolumab plus ipilimumab for first-line mNSCLC (PD-L1 tumor expression ≥1%) On May 15, 2020, the Food and Drug Administration approved the combination of nivolumab (OPDIVO, Bristol-Myers Squibb Co.) plus ipilimumab (YERVOY, Bristol-Myers Squibb Co.)
114919
One drug called ipilimumab (Yervoy®) blocks a checkpoint protein called CTLA-4. Two additional drugs, pembrolizumab (Keytruda®) and nivolumab (Opdivo®), target another checkpoint protein called PD-1. A third drug, atezolizumab (Tecentriq®), targets one called PD-L1.
1213565
Ninlaro is a brand-name prescription medication that's used to treat multiple myeloma in adults. This condition is a rare type of cancer that affects certain white blood cells called plasma cells. With multiple myeloma, normal plasma cells become cancerous and are called myeloma cells.
639717
The National Institute for Health and Care Excellence (NICE) has today announced that major new breast cancer drugs palbociclib (Ibrance, Pfizer) and ribociclib (Kisqali, Novartis) are to be made routinely available to NHS patients in England, in new draft guidance following their technology appraisals.
915577
['ImmunoGen (NASDAQ:IMGN)', 'Kadmon Holdings (NYSE:KDMN)', 'Corcept Therapeutics (NASDAQ:CORT)', 'Supernus Pharmaceuticals (NASDAQ:SUPN)', 'G1 Therapeutics (NASDAQ:GTHX)', 'Vertex Pharmaceuticals (NASDAQ:VRTX)', 'Dynavax (NASDAQ:DVAX)']
650105
['Atezolizumab.', 'Avastin (Bevacizumab)', 'Bevacizumab.', 'Cabometyx (Cabozantinib-S-Malate)', 'Cabozantinib-S-Malate.', 'Cyramza (Ramucirumab)', 'Keytruda (Pembrolizumab)', 'Lenvatinib Mesylate.']
592723
Pharmaceutical company Bristol-Myers Squibb has today announced that the HSE has approved the immunotherapy drug nivolumab for use in Ireland in patients suffering from advanced lung cancer if they have already failed prior chemotherapy treatment.
504707
['Merck & Co.', 'Acceleron Pharma.', 'Aderis Pharmaceuticals.', 'Agios Pharmaceuticals.', 'Alkermes.', 'Alnylam Pharmaceuticals.', 'Amgen.', 'Alzheon.']
124160
['trastuzumab (Herceptin)', 'pertuzumab (Perjeta)', 'bevacizumab (Avastin)', 'rituximab (Mabthera)']
920005
Ipilimumab (Yervoy®) Immunotherapy is cancer treatment that stimulates the body's immune system to fight cancer, such as melanoma, anywhere in the body. Immunotherapy is systemic, which means that the treatments reach all parts of your body through the bloodstream.
76662
Basel, December 13, 2018 - Novartis today announced that the European Commission (EC) has approved Xolair® (omalizumab) prefilled syringe (PFS) for self-administration, allowing patients with severe allergic asthma (SAA) and chronic spontaneous urticaria (CSU) to administer their own treatment.
1439357
Immunotherapy includes medications that cause an immune response which kills cancer cells. Immunotherapy also includes treatment vaccines which boost the immune system's response to cancer cells. Medicare may cover immunotherapy cancer treatment if it determined to be medically necessary.
718318
LIBTAYO is a type of immunotherapy treatment called a programmed death receptor-1 (PD-1) inhibitor. LIBTAYO is not chemotherapy or radiation therapy.
776994
['reslizumab (Cinqair)', 'mepolizumab (Nucala)', 'omalizumab (Xolair)', 'benralizumab (Fasenra)']
287277
['Pfizer — $51.75 billion.', 'Roche — $50 billion.', 'Novartis — $47.45 billion.', 'Merck — $46.84 billion.', 'GlaxoSmithKline — $43.54 billion.', 'Johnson & Johnson — $42.1 billion.', 'AbbVie — $33.27 billion.', 'Sanofi — $27.77 billion.']
135727
Currently, there are only three insulin manufacturers serving the U.S. market: Eli Lilly, Novo Nordisk, and Sanofi. Almost 100 years ago, the discovery of insulin, derived from animal sources, literally began to save human lives.
486163
Tecentriq is an immune checkpoint inhibitor medicine that stops PD-1 from binding to PD-L1, which allows T cells to attack the cancer cells.